CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
Galileo 🔭
start up
United States
- San Francisco, California
- 16/10/2024
- Series B
- $45,000,000
Galileo is the leading platform for enterprise GenAI evaluation and observability. Our comprehensive suite of products support builders across the new AI development workflow—from fine-tuning LLMs to developing, testing, monitoring, and securing their AI applications. Each product is powered by our research-backed evaluation metrics. Today, Galileo is used by 100s of AI teams from startups to Fortune 50 enterprises, including Twilio, Comcast, and HP.
- Industry Software Development
- Website https://www.galileo.ai/
- LinkedIn https://www.linkedin.com/company/galileo-ai/
Related People
Vikram ChatterjiFounder
United States -
San Francisco, California
Building the enterprise-grade Evaluations and Observability platform for the AI software era, powered by Evaluation Foundation Models.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)